SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-189423
Filing Date
2019-07-05
Accepted
2019-07-05 06:31:07
Documents
4
Period of Report
2019-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d761372d6k.htm 6-K 366279
2 GRAPHIC g761372img1.jpg GRAPHIC 6759
3 GRAPHIC g761372img2.jpg GRAPHIC 7228
4 GRAPHIC g761372nimg1.jpg GRAPHIC 7275
  Complete submission text file 0001193125-19-189423.txt   397041
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 19943160
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences